POLE and neoplasm: To reveal the molecular mechanism underlying the role of POLE mutations in endometrial cancer, we selected four hotspot EDMs, including P286R, V411L, R375Q, and P452L, and assessed their pathogenicity based on the effects on catalytic activities of Polε and tumor cell behavior.